Carl Zeiss Meditec Ag
Clinical trials sponsored by Carl Zeiss Meditec Ag, explained in plain language.
-
A new lens design aims to improve vision after cataract surgery
Disease control CompletedThis trial tests a new type of intraocular lens, the CT LUCIA 621P, designed to improve vision after cataract surgery. The lens has a special shape that may correct vision more precisely than standard lenses. Researchers will measure how well people see at distance and intermedia…
Phase: PHASE4 • Sponsor: Carl Zeiss Meditec AG • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a new lens give sharper sight at all distances?
Disease control CompletedThis trial investigates how well a new multifocal intraocular lens, the AT ELANA, improves vision in people having cataract or refractive lens exchange surgery. About 69 participants will receive the lens in both eyes and be followed for 12 months to measure visual sharpness and …
Phase: NA • Sponsor: Carl Zeiss Meditec AG • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New lens implant shows promise for cataract patients
Disease control CompletedThis study tested a new lens called 621 in 105 adults having cataract surgery. The lens was implanted during standard surgery to replace the cloudy natural lens. Researchers checked how well patients could see 6 months after surgery and monitored for any safety issues. The goal w…
Phase: NA • Sponsor: Carl Zeiss Meditec AG • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Cataract lens still clear after 2 years? study checks for glistening
Knowledge-focused CompletedThis study checked how well a specific intraocular lens (CT LUCIA 621P) holds up at least two years after cataract surgery. Researchers looked for tiny fluid-filled bubbles called glistening and measured vision in 33 patients. The goal was to see if the lens remains safe and clea…
Sponsor: Carl Zeiss Meditec AG • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC